Halozyme Therapeutics Inc (HALO)

[maumar]

"sc will be next step in China."

Did they say that sc has NOT been approved yet? It was not clear to me. In any case, China will inevitably become a huge market for big pharma in the not too distant future and Halo should benefit as well.

What kind of royalties are you expecting for Q 4 '16? I'm thinking $15M. We should get to $25M by the end of the year. If Mabthera sc is approved, that alone should add at least $30M of royalties in '18, I would hope.